We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

That list includes eight serotypes not included in any currently licensed pneumococcal vaccine, said Merck, which reported the results today at the International Symposium on Pneumococci and ...

The bioreactors market is expected to grow at 12.6% CAGR from 2024 to 2030. It is expected to reach above USD 24.24 billion by 2030 from USD 10.56 billion in 2023. Get the PDF Sample Copy of this ...

Global donor egg IVF (in-vitro fertilization) market is estimated to be valued at USD 2.85 Bn in 2024 and is expected to reach USD 5.30 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9 ...

Merck said on Thursday its experimental antibody ... The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the company ...

Merck in Germany was possibly the earliest company ... in 1951 alone Pfizer opened subsidiaries in nine new countries. The list of novel drugs from the post-war era speaks for itself.

Merck (NYSE:MRK) announced Wednesday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent pneumonia, generated positive immune responses in a Phase 3 trial for ...